CD14 and neurodegenerative disease: We next used quantitative immunoblotting to verify the MS data for a subset of candidate biomarkers, with a focus on proteins known to have a role in neuron biology, neuroinflammation, neurodegenerative diseases, and/or pathophysiology in general: NP1, Ch3L1, CD14, and IGFBP2.